( MENAFN - GlobeNewsWire - Nasdaq) The Global Clinical Trial Imaging market Size was Valued at USD 1.96 Billion in 2023, the Worldwide Clinical Trial Imaging Market Size is Expected to Reach USD 4.46 Billion by 2033, according to a research report published by Spherical Insights & Consulting.
Companies covered: Intrinsic Imaging, BioTelemetry, ProScan Imaging, Medpace, Biomedical Systems Corp, IXICO plc, Resonance Health, Navitas Life Sciences, Cardiovascular Imaging Technologies, Radiant Sage LLC, WCG Clinical, Medidata, WorldCare Clinical, Image Core Lab, and Other Key Vendors New York, United States, June 10, 2024 (GLOBE NEWSWIRE) -- The Global Clinical Trial Imaging Market Size is to Grow from USD 1.96 Billion in 2023 to USD 4.46 Billion by 2033, at a CAGR of 8.
57% during the projected period. Get a Sample PDF Brochure: A clinical trial is a process used to develop, test, and evaluate novel drugs while taking into account their effects on people and potential treatments. Comprehensive clinical trials are conducted to identify interesting compounds and safety testing is carried out to identify any potential risks before novel drugs are brought to market.
The firms that develop and manufacture imaging software and hardware for use in clinical trials, along with those that provide imaging services such image management, analysis, and acquisition, comprise the clinical trial imaging market. The market is driven by the increase in clinical trials conducted worldwide and the gr.
